Skip to content

K-Stock Briefing

https://kstockbriefing.com

  • About Us
  • Weekly News
  • IR Room
  • RESEARCH
  • Disclosures
    • Semiconductors
    • Bio & Healthcare
    • Defense
    • Shipbuilding
    • Automotive
  • Toggle search form

[Disclosure] LEENO Industrial (058470) – Decision on Stock Split / 2025-02-11

Posted on February 11, 2025August 4, 2026 By K-STOCK Editor No Comments on [Disclosure] LEENO Industrial (058470) – Decision on Stock Split / 2025-02-11

Fact Source: Financial Supervisory Service DART

💡 3-Second Summary

LEENO Industrial has resolved on a 5-for-1 stock split, reducing the par value per share from KRW 500 to KRW 100 to expand liquidity.

📊 [Key Disclosure Details & Financial Figures]

  • Stock Split Details:
    • Par Value per Share: (Before) KRW 500 → (After) KRW 100
    • Total Issued Common Shares: (Before) 15,242,370 shares → (After) 76,211,850 shares
  • Purpose of Stock Split: Expansion of circulating shares (liquidity)
  • Key Schedule:
    • General Meeting of Shareholders (AGM) Date: March 26, 2025
    • Effective Date of New Shares: April 14, 2025
    • Scheduled Trading Suspension Period: April 10, 2025 – April 24, 2025
    • Scheduled Listing Date of New Shares: April 25, 2025
  • Board Resolution Date: February 11, 2025 (2 Outside Directors present, Statutory Auditor present)
  • Other Details: To be presented as an agenda item at the AGM on March 26, 2025. Schedule subject to change based on AGM results and regulatory consultations. Period for submission of old share certificates omitted due to electronic securities implementation.

📝 Editor’s Comment (Key Follow-up Checkpoint)

📌 Verification of AGM Approval and Stock Split Timeline

To enhance share liquidity, the company decided to split its par value from KRW 500 to KRW 100, submitting the resolution to the AGM scheduled for March 26, 2025. Verifying the AGM voting outcome as well as the scheduled trading suspension period (April 10 to April 24, 2025) and new share listing date (April 25, 2025) is essential. Relevant details can be cross-checked in the upcoming ‘Results of Annual General Meeting of Shareholders’ and modification listing disclosures on DART.

📢 Disclaimer and Source Information

Source: This content was structured and regenerated based on official data submitted to the Financial Supervisory Service’s Data Analysis, Retrieval and Transfer System (DART).

Investment Risk Notice: This content is provided solely for informational and linguistic reference purposes. Under no circumstances does it constitute financial advice or a recommendation to buy or sell any specific security. All investment decisions and financial responsibilities rest entirely with the individual investor.

Contact: For compliance inquiries or copyright concerns, please contact ksb220805@gmail.com.

Search by
Company Name or Stock Ticker.
Disclosures, Semiconductors

Post navigation

Previous Post: [Disclosure] SK Square (402340) – Change in Revenue or Profit/Loss Structure Exceeding 30% (15% for Large Enterprises) / 2025-02-11
Next Post: [Disclosure] PSK Holdings (031980) – Change in Revenue or Income Structure Exceeding 30% (15% for Large Corporations) / 2025-02-11

Related Posts

[Disclosure] Celltrion (068270) – Decision on Acquisition of Other Corporation Shares and Capital Securities (Correction) / 2026-05-11 Disclosures
[Disclosure] Celltrion (068270) – Application for Phase 3 Clinical Trial Plan for CT-P51 (Keytruda Biosimilar) in Korea / 2025-01-15 Disclosures
[Disclosure] ISU PETASYS (007660) – Advance Notice of Designation as Unfaithful Disclosure Company / 2025-02-04 Semiconductors
[Disclosure] Hanwha Aerospace (012450) Announces Corporate Investor Relations (IR) Event in Singapore for Major Overseas Institutional Investors Disclosures
[Disclosure] Hanmi Semiconductor (042700) – Provisional Financial Results (Consolidated) / 2026-05-15 Semiconductors
[Disclosure] Hanwha Systems (272210) Signs KRW 1.2T Supply Contract with LIG Nex1 for ‘SA-MSAM Project Multifunction Radar Mass Production’ (Cheongung-II MFR Export to Saudi Arabia) Disclosures

Leave a Reply Cancel reply

You must be logged in to post a comment.

  • [Disclosure] Hanwha Ocean (042660) – Clarification on Rumors or Reports (Unconfirmed) / 2026-08-07August 7, 2026
  • [Disclosure] ALTEOGEN (196170) – Exclusive License Agreement for Recombinant Human Hyaluronidase Product ALT-B4 / 2026-08-05August 5, 2026
  • [Disclosure] ALTEOGEN (196170) – Ex-Rights (Bonus Issue) / 2026-08-04August 4, 2026
  • [Disclosure] ALTEOGEN (196170) – Market Measures on Stock Futures and Options (Bonus Issue) / 2026-08-04August 4, 2026
  • [Disclosure] Celltrion (068270) – CT-P44 (Darzalex Biosimilar) Korea Phase 3 Clinical Trial Plan Amendment Application / 2026-08-03August 3, 2026

Copyright © 2026 K-Stock Briefing.

Powered by PressBook Grid Dark theme